Previous 10 | Next 10 |
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced plans to present at the upc...
2023-11-10 18:31:02 ET Hyperfine, Inc. (HYPR) Q3 2023 Earnings Call November 9, 2023 04:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financi...
2023-11-09 16:59:16 ET More on Hyperfine Hyperfine: Swoop-Ing In On The Low-Field MRI Opportunity Hyperfine shares up after receiving FDA clearance for updated AI-powered software Seeking Alpha’s Quant Rating on Hyperfine For further details see: H...
2023-11-09 16:32:20 ET More on Hyperfine Hyperfine: Swoop-Ing In On The Low-Field MRI Opportunity Hyperfine's Portable MRI Scanner Will Likely Be A Winner Hyperfine Inc. (HYPR) Q2 2023 Earnings Call Transcript Hyperfine shares up after receiving FDA clearance...
GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Hyperfine Inc. (HYPR) is expected to report $-0.15 for Q3 2023
2023-11-04 12:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. We highlight October investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ideas hard to come...
Results from study presented at the 2023 A sia-Pacific Extracorporeal Life Support Organization (APELSO) meeting Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced that it will report financial results for the ...
News, Short Squeeze, Breakout and More Instantly...
Portable ultra-low-field MR brain imaging provides affordable and accessible technology that may help physicians monitor ARIA and Alzheimer's disease progression in diverse professional care settings. Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has ...
- Led by Edmond Knopp, MD, VP of Medical Affairs - Welcoming three KOLs to discuss clinical developments in ultra-low-field (ULF) MR imaging Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared por...
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared por...